Searching for other possible roles for GPR158, we identified a published microarray study showing GPR158 as one of the genes upregulated in androgen ablation-resistant metastatic tumor as compared to primary prostate tumors [9]. This evidence concerns the gene GPR158 and metastatic neoplasm.